Business Context and Reporting Period
This Form 8-K Current Report was filed by Abbott Laboratories on October 13, 2005. The report addresses a specific corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a personnel announcement and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director:
- Mr. A. Barry Rand informed Abbott Laboratories of his resignation from the Board of Directors.
- The resignation is effective as of January 15, 2006.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document focuses solely on the director's resignation.
Investor Verification Checklist
- Confirm the effective date of Mr. Rand's resignation (January 15, 2006).
- Verify if a replacement director has been nominated or elected to fill the vacancy.
- Review the company's most recent 10-Q or 10-K for financial performance data not included in this 8-K.